NCT02260076View on ClinicalTrials.gov

Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

March 31, 2002

Conditions
Healthy
Interventions
DRUG

PEG 400

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY